Automated high-sensitivity proteomics platform with NULISA chemistry and ARGO
Alamar Biosciences sells an automated protein-analysis system built on its NULISA chemistry, with qPCR and NGS readouts. Lab automation tools (Tecan, Opentrons) alongside Benchling and a Delta Lake/Unity Catalog data layer point to a company pairing instrument hardware with data infrastructure. Post-IPO pressures show up clearly: equity controls, global consolidation and NetSuite/SAP finance tooling sit next to an IVD immunoassay push and manufacturing transfer.
Alamar Biosciences is a public life-science tools company headquartered in Fremont, California, founded in 2018 and employing 201–500 people. It develops automated, high-throughput solutions for ultra-sensitive protein measurement across multiplex levels. Its proprietary NULISA chemistry supports both qPCR and NGS readouts, and its inflammation panel covering 200+ immune and inflammatory markers runs on the ARGO System. The company hires in the United States, United Kingdom and Germany, supporting installed instruments with remote and on-site customer support.
Alamar's stack includes Python, C#, Flask, Streamlit, Shiny, Delta Lake, Unity Catalog, Benchling, Tecan, Opentrons, NetSuite, SAP, Salesforce, HubSpot, Power BI, JMP and GraphPad Prism.
Alamar Biosciences hires in the United States, United Kingdom and Germany, with product, operations, research and support among its most active hiring areas.
Current initiatives include IVD immunoassay development on NULISA, technology transfer to manufacturing, QC scale-up, scalable customer support processes and equity system enhancements.
Other companies in the same industry, closest in size
Alamar Biosciences, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.